OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma osteopontin as a biomarker of Alzheimer’s disease and vascular cognitive impairment
Yuek Ling Chai, Joyce R. Chong, Ainiah Rushdiana Raquib, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease
Sebastiaan De Schepper, Judy Z. Ge, Gerard Crowley, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 3, pp. 406-415
Open Access | Times Cited: 148

Role of SARS-CoV-2 Spike-Protein-Induced Activation of Microglia and Mast Cells in the Pathogenesis of Neuro-COVID
Theoharis C. Theoharides, Duraisamy Kempuraj
Cells (2023) Vol. 12, Iss. 5, pp. 688-688
Open Access | Times Cited: 53

Immune Activation in Alzheimer Disease
Arnaud Mary, Renzo Mancuso, Michael T. Heneka
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 585-613
Closed Access | Times Cited: 19

Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer’s disease
Shuo Chen, Yuzhou Chang, Liangping Li, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 69

Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases
Anjana Sajeev, Mangala Hegde, Sosmitha Girisa, et al.
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1185-1185
Open Access | Times Cited: 42

Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Antía Custodia, Marta Aramburu-Núñez, Mariña Rodríguez‐Arrizabalaga, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 962-962
Open Access | Times Cited: 26

Blood-based biomarkers of cerebral small vessel disease
Liu‐Yun Wu, Yuek Ling Chai, Irwin K. Cheah, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102247-102247
Open Access | Times Cited: 13

Metabolic stress and age drive inflammation and cognitive decline in mice and humans
Sarah E. Elzinga, Kai Guo, Ali Turfah, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1

Gene regulation by antisense transcription: A focus on neurological and cancer diseases
Sajad Najafi, Shing Cheng Tan, Pourya Raee, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112265-112265
Open Access | Times Cited: 44

Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia
Marie‐Laure Charpignon, Bella Vakulenko‐Lagun, Bang Zheng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36

An overview of the pharmacological activities of scopoletin against different chronic diseases
Parama Dey, Sosmitha Girisa, Elina Khatoon, et al.
Pharmacological Research (2022) Vol. 179, pp. 106202-106202
Closed Access | Times Cited: 34

A Therapeutic Nanovaccine that Generates Anti‐Amyloid Antibodies and Amyloid‐specific Regulatory T Cells for Alzheimer's Disease
Mungyo Jung, Songmin Lee, Sohui Park, et al.
Advanced Materials (2022) Vol. 35, Iss. 3
Closed Access | Times Cited: 30

Immunoregulatory Roles of Osteopontin in Diseases
L F Wang, Xiaoyin Niu
Nutrients (2024) Vol. 16, Iss. 2, pp. 312-312
Open Access | Times Cited: 7

Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
Zhuo‐Ting Liu, Ming‐Han Liu, Yan Xiong, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5720-5739
Open Access | Times Cited: 7

Serum Placental Growth Factor as a Marker of Cerebrovascular Disease Burden in Alzheimer’s Disease
Liu‐Yun Wu, Joyce R. Chong, Jenny Chong, et al.
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 3, pp. 1289-1298
Closed Access | Times Cited: 6

Research progress in Alzheimer's disease and bone-brain axis
Fan Zhang, Wei Zhang
Ageing Research Reviews (2024) Vol. 98, pp. 102341-102341
Open Access | Times Cited: 6

Associations of cortical SPP1 and ITGAX with cognition and common neuropathologies in older adults
Kátia de Paiva Lopes, Lei Yu, Xianli Shen, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 525-537
Open Access | Times Cited: 14

Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel Disease
Kaung H. T. Salai, Liu‐Yun Wu, Joyce R. Chong, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 525-525
Open Access | Times Cited: 12

Research trends and hotspots of post-stroke cognitive impairment: a bibliometric analysis
Xiansu Chi, Xueming Fan, Guo-Jing Fu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12

Correlations of Plasma Biomarkers and Imaging Characteristics of Cerebral Small Vessel Disease
Qianqian Kong, Xinxin Xie, Ziyue Wang, et al.
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 269-269
Open Access | Times Cited: 4

Osteopontin: A novel marker of pre‐symptomatic sporadic Alzheimer's disease
Marc James Quesnel, Anne Labonté, Cynthia Picard, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6008-6031
Open Access | Times Cited: 4

The potential link between the development of Alzheimer’s disease and osteoporosis
Fariha Nasme, Jyotirmaya Behera, Prisha Tyagi, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access

Scientific status analysis of exercise benefits for vascular cognitive impairment: Evidence of neuroinflammation
Wei Zhang, Jing He, Yuxin Wang, et al.
Journal of Neuroimmunology (2025) Vol. 402, pp. 578574-578574
Closed Access

Page 1 - Next Page

Scroll to top